相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance
Sonali Bahl et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors
Mihai I. Truica et al.
CANCER RESEARCH (2021)
Arginine Methyltransferase PRMT1 Regulates p53 Activity in Breast Cancer
Li-Ming Liu et al.
LIFE-BASEL (2021)
Pathophysiological significance of N-myc downstream-regulated gene 2 in cancer development through protein phosphatase 2A phosphorylation regulation
Kazuhiro Morishita et al.
CANCER SCIENCE (2021)
Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Nina G. Steele et al.
CLINICAL CANCER RESEARCH (2021)
Nuclear organization and regulation of the differentiated state
Eliya Bitman-Lotan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma
Yoshihiro Otani et al.
NEURO-ONCOLOGY (2021)
Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression
Ramesh Butti et al.
ONCOGENE (2021)
Protein arginine methyltransferases and hepatocellular carcinoma: A review
Yu Lei et al.
TRANSLATIONAL ONCOLOGY (2021)
Lamin post-translational modifications: emerging toggles of nuclear organization and function
Laura A. Murray-Nerger et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows a Strong Prognostic Value in Triple Negative Breast Cancer Patients
Marta Sanz-Alvarez et al.
CANCERS (2021)
Nuts and bolts of the salt-inducible kinases (SIKs)
Nicola J. Darling et al.
BIOCHEMICAL JOURNAL (2021)
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
Stephin J. Vervoort et al.
CELL (2021)
Protein phosphatases in the RNAPII transcription cycle: erasers, sculptors, gatekeepers, and potential drug targets
Giacomo Cossa et al.
GENES & DEVELOPMENT (2021)
PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
Michael K. C. Lee et al.
CANCERS (2021)
Druggable cancer phosphatases
Julia P. Vainonen et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
Bing Yao et al.
GENOME MEDICINE (2021)
Protein Phosphatase 2A Mediates YAP Activation in Endothelial Cells Upon VEGF Stimulation and Matrix Stiffness
Xiao Jiang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
The many faces of cancer evolution
Giovanni Ciriello et al.
ISCIENCE (2021)
Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents
David L. Brautigan et al.
CLINICAL SCIENCE (2021)
The Role of N-myc Downstream-Regulated Gene Family in Glioma Based on Bioinformatics Analysis
Ting Tang et al.
DNA AND CELL BIOLOGY (2021)
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
Tamara Mirzapoiazova et al.
MOLECULAR CANCER THERAPEUTICS (2021)
SPT5 stabilizes RNA polymerase II , orchestrates transcription cycles, and maintains the enhancer landscape
Shibin Hu et al.
MOLECULAR CELL (2021)
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma
Virginia Giuliani et al.
NATURE COMMUNICATIONS (2021)
Review of PP2A Tumor Biology and Antitumor Effects of PP2A Inhibitor LB100 in the Nervous System
Jean-Paul Bryant et al.
CANCERS (2021)
The emerging role of epigenetic therapeutics in immuno-oncology
Michael J. Topper et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2low ATL and various cancer cells
Tomonaga Ichikawa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation
Anirban Kundu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1
Otto Kauko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age
Rita Ferreira et al.
CELLS (2020)
被撤回的出版物: Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2 (Retracted article. See vol. 185, pg. 3058, 2022)
Ken Morita et al.
CELL (2020)
Piecing Together a Broken Tumor Suppressor Phosphatase for Cancer Therapy
Jukka Westermarck et al.
CELL (2020)
Selective PP2A Enhancement through Biased Heterotrimer Stabilization
Daniel Leonard et al.
CELL (2020)
Phosphorylated Lamin A/C in the Nuclear Interior Binds Active Enhancers Associated with Abnormal Transcription in Progeria
Kohta Ikegami et al.
DEVELOPMENTAL CELL (2020)
Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery
Ryan D. Martin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The PRR14 heterochromatin tether encodes modular domains that mediate and regulate nuclear lamina targeting
Kelly L. Dunlevy et al.
JOURNAL OF CELL SCIENCE (2020)
Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5
Tao He et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Nucleoporin 153 links nuclear pore complex to chromatin architecture by mediating CTCF and cohesin binding
Shinichi Kadota et al.
NATURE COMMUNICATIONS (2020)
Hypericin-Loaded Transferrin Nanoparticles Induce PP2A-Regulated BMI1 Degradation in Colorectal Cancer-Specific Chemo-Photodynamic Therapy
Mohammed Nadim Sardoiwala et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse
Lingfei Jia et al.
CELL STEM CELL (2020)
Protein Arginine Methyltransferase 5 as a Therapeutic Target forKRASMutated Colorectal Cancer
David Shifteh et al.
CANCERS (2020)
A serine/threonine protein PIM kinase as a biomarker of cancer and a target for anti -tumor therapy
Nagesh Kishan Panchal et al.
LIFE SCIENCES (2020)
Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update
Tizhi Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Integrator Recruits Protein Phosphatase 2A to Prevent Pause Release and Facilitate Transcription Termination
Kai-Lieh Huang et al.
MOLECULAR CELL (2020)
Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy
Dorota Komar et al.
CLINICAL EPIGENETICS (2020)
Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
Hirva Mamdani et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The Molecular 'Myc-anisms' behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
Jessica McAnulty et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Identification of Integrator-PP2A complex (INTAC), an RNA polymerase II phosphatase
Hai Zheng et al.
SCIENCE (2020)
Post-translational modifications of PRC2: signals directing its activity
Yiqi Yang et al.
EPIGENETICS & CHROMATIN (2020)
Proximity labeling in mammalian cells with TurboID and split-TurboID
Kelvin F. Cho et al.
NATURE PROTOCOLS (2020)
Non-genetic mechanisms of therapeutic resistance in cancer
Jean-Christophe Marine et al.
NATURE REVIEWS CANCER (2020)
Protein phosphatases in chromatin structure and function
Raquel Sales Gil et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer
A. J. Fritz et al.
GENES CHROMOSOMES & CANCER (2019)
Division of labour between PP2A-B56 isoforms at the centromere and kinetochore
Giulia Vallardi et al.
ELIFE (2019)
Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer
Ion Cristobal et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Validation of the γH2AX biomarker for genotoxicity assessment: a review
B. Kopp et al.
ARCHIVES OF TOXICOLOGY (2019)
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
Wenjing Su et al.
CANCER CELL (2019)
Epidrugs: targeting epigenetic marks in cancer treatment
Cristiana Libardi Miranda Furtado et al.
EPIGENETICS (2019)
Hepatocyte PRMT1 protects from alcohol induced liver injury by modulating oxidative stress responses
Jie Zhao et al.
SCIENTIFIC REPORTS (2019)
Checkpoint signaling and error correction require regulation of the MPS1 T-loop by PP2A-B56
Daniel Hayward et al.
JOURNAL OF CELL BIOLOGY (2019)
H3K9me2 orchestrates inheritance of spatial positioning of peripheral heterochromatin through mitosis
Andrey Poleshko et al.
ELIFE (2019)
Histone lysine methyltransferases in biology and disease
Dylan Husmann et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma
Brittany L. Allen-Petersen et al.
CANCER RESEARCH (2019)
TET2 stabilization by 14-3-3 binding to the phosphorylated Serine 99 is deregulated by mutations in cancer
Hao Chen et al.
CELL RESEARCH (2019)
Direct activation of PP2A for the treatment of tyrosine kinase inhibitor-resistant lung adenocarcinoma
Rita Tohme et al.
JCI INSIGHT (2019)
Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma
Shuyu Hao et al.
NEURO-ONCOLOGY (2018)
PPP2R5A: A multirole protein phosphatase subunit in regulating cancer development
Ziming Mao et al.
CANCER LETTERS (2018)
Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer
Kimberly McClinch et al.
CANCER RESEARCH (2018)
Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
Bob Meeusen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
Otto Kauko et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Therapeutic targeting of PP2A
Caitlin M. O'Connor et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
Lingdi Zhang et al.
NATURE COMMUNICATIONS (2018)
Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back
Jukka Westermarck
FEBS JOURNAL (2018)
A Cdk9-PP1 switch regulates the elongation-termination transition of RNA polymerase II
Pabitra K. Parua et al.
NATURE (2018)
Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
Di Wu et al.
NATURE (2018)
SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment
Yu-Hsiang Huang et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals
Yulong Su et al.
GENES & DEVELOPMENT (2018)
BRD4 and Cancer: going beyond transcriptional regulation
Benedetta Donati et al.
MOLECULAR CANCER (2018)
Epigenetic Priming in Cancer Initiation
Carolina Vicente-Duenas et al.
TRENDS IN CANCER (2018)
Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson's Disease
Qimei Wu et al.
MOLECULAR NEUROBIOLOGY (2017)
HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer
N. Stojanovic et al.
ONCOGENE (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Jaya Sangodkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Persistent phosphorylation at specific H3 serine residues involved in chemical carcinogen-induced cell transformation
Xiaonian Zhu et al.
MOLECULAR CARCINOGENESIS (2017)
THE GREATEST HITS OF THE HUMAN GENOME
Elie Dolgin
NATURE (2017)
TET-mediated active DNA demethylation: mechanism, function and beyond
Xiaoji Wu et al.
NATURE REVIEWS GENETICS (2017)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
Split-BioID a conditional proteomics approach to monitor the composition of spatiotemporally defined protein complexes
Isabel Myriam Schopp et al.
NATURE COMMUNICATIONS (2017)
The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia
Giusy Di Conza et al.
CELL REPORTS (2017)
β-Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α-PP2A-Mediated Dephosphorylation
Kate L. Weeks et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Matrix Mechanics Influence Fibroblast-Myofibroblast Transition by Directing the Localization of Histone Deacetylase 4
Yanfen Li et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2017)
PP2A-B56γ is required for an efficient spindle assembly checkpoint
Prajakta Varadkar et al.
CELL CYCLE (2017)
Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma
Demeng Chen et al.
CELL STEM CELL (2017)
Writing, erasing and reading histone lysine methylations
Kwangbeom Hyun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56
Jiao Wang et al.
EMBO REPORTS (2017)
All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase
Jaya Sangodkar et al.
FEBS JOURNAL (2016)
Approaches to Study Phosphatases
Sara Fahs et al.
ACS CHEMICAL BIOLOGY (2016)
PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling
Ashley L. Hein et al.
CANCER RESEARCH (2016)
Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth
Dorien Haesen et al.
CANCER RESEARCH (2016)
Overview of CDK9 as a target in cancer research
Fatima Morales et al.
CELL CYCLE (2016)
Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways
Seong M. Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Melatonin relieves neuropathic allodynia through spinal MT2-enhanced PP2Ac and downstream HDAC4 shuttling-dependent epigenetic modification of hmgb1 transcription
Tzer-Bin Lin et al.
JOURNAL OF PINEAL RESEARCH (2016)
A Conserved Motif Provides Binding Specificity to the PP2A-B56 Phosphatase
Emil Peter Thrane Hertz et al.
MOLECULAR CELL (2016)
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shaokun Shu et al.
NATURE (2016)
Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential
M-H Hung et al.
ONCOGENE (2016)
Expanding the PP2A Interactome by Defining a B56-Specific SLiM
Xinru Wang et al.
STRUCTURE (2016)
H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes
Justin S. Becker et al.
TRENDS IN GENETICS (2016)
Biochemical reconstitution of TET1-TDG-BER-dependent active DNA demethylation reveals a highly coordinated mechanism
Alain R. Weber et al.
NATURE COMMUNICATIONS (2016)
Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape
Fan Liu et al.
NATURE REVIEWS CANCER (2016)
The broken Off switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance
Peter P. Ruvolo
BBA CLINICAL (2016)
LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential
Christopher S. Hong et al.
CANCER BIOLOGY & THERAPY (2015)
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation
Maria Antonietta Mazzola et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma
Timothy J. Underwood et al.
JOURNAL OF PATHOLOGY (2015)
Post-translational Modifications Regulate Class IIa Histone Deacetylase (HDAC) Function in Health and Disease
Rommel A. Mathias et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma
Ira K. Gordon et al.
MOLECULAR CANCER THERAPEUTICS (2015)
PP2A-B56ε complex is involved in dephosphorylation of γ-H2AX in the repair process of CPT-induced DNA double-strand breaks
Xiuying Li et al.
TOXICOLOGY (2015)
Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation
Kevin Myant et al.
CELL REPORTS (2015)
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
N. C. Hait et al.
ONCOGENESIS (2015)
Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms
Kate L. Weeks et al.
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications
John Camm et al.
AMERICAN HEART JOURNAL (2014)
Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis
Xueli Bai et al.
CANCER LETTERS (2014)
SETting OP449 into the PP2A-Activating Drug Family
Paolo Neviani et al.
CLINICAL CANCER RESEARCH (2014)
Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
Anupriya Agarwal et al.
CLINICAL CANCER RESEARCH (2014)
Novel Mechanism of Negative Regulation of 1,25-Dihydroxyvitamin D3-induced 25-Hydroxyvitamin D3 24-Hydroxylase (Cyp24a1) Transcription EPIGENETIC MODIFICATION INVOLVING CROSS-TALK BETWEEN PROTEIN-ARGININE METHYLTRANSFERASE 5 AND THE SWI/SNF COMPLEX
Tanya Seth-Vollenweider et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer
Amy S. Farrell et al.
MOLECULAR CANCER RESEARCH (2014)
Inhibition of Protein Phosphatase 2A Enhances Cytotoxicity and Accessibility of Chemotherapeutic Drugs to Hepatocellular Carcinomas
Xue-Li Bai et al.
MOLECULAR CANCER THERAPEUTICS (2014)
PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential
Ion Cristobal et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair
Peng Lv et al.
ONCOTARGET (2014)
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
Joshua J. Oaks et al.
BLOOD (2013)
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Parthasarathy Seshacharyulu et al.
CANCER LETTERS (2013)
Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target
Anchit Khanna et al.
CANCER RESEARCH (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Chromatin Position Effects Assayed by Thousands of Reporters Integrated in Parallel
Waseem Akhtar et al.
CELL (2013)
LBR and Lamin A/C Sequentially Tether Peripheral Heterochromatin and Inversely Regulate Differentiation
Irina Solovei et al.
CELL (2013)
PP2A regulatory subunit Bα controls endothelial contractility and vessel lumen integrity via regulation of HDAC7
Maud Martin et al.
EMBO JOURNAL (2013)
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
Sahar A. Saddoughi et al.
EMBO MOLECULAR MEDICINE (2013)
Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells
Chun-Yu Liu et al.
HAEMATOLOGICA (2013)
Direct binding between BubR1 and B56-PP2A phosphatase complexes regulate mitotic progression
Thomas Kruse et al.
JOURNAL OF CELL SCIENCE (2013)
Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting
Shwu-Yuan Wu et al.
MOLECULAR CELL (2013)
R Loops Are Linked to Histone H3 S10 Phosphorylation and Chromatin Condensation
Maikel Castellano-Pozo et al.
MOLECULAR CELL (2013)
The Human Protein PRR14 Tethers Heterochromatin to the Nuclear Lamina during Interphase and Mitotic Exit
Andrey Poleshko et al.
CELL REPORTS (2013)
Protein arginine methyltransferases and cancer
Yanzhong Yang et al.
NATURE REVIEWS CANCER (2013)
DNA Sequence-Dependent Compartmentalization and Silencing of Chromatin at the Nuclear Lamina
Joseph M. Zullo et al.
CELL (2012)
Coordination of Kinase and Phosphatase Activities by Lem4 Enables Nuclear Envelope Reassembly during Mitosis
Claudio Asencio et al.
CELL (2012)
H3K27 methylation and H3S28 phosphorylation-dependent transcriptional regulation by INHAT subunit SET/TAF-Iβ
Ji-Young Kim et al.
FEBS LETTERS (2012)
Reactivating PP2A by FTY720 as a Novel therapy for AML with C-KIT tyrosine kinase domain mutation
Yan Yang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
J. Wang et al.
ONCOGENE (2012)
CIP2A is a target of bortezomib in human triple negative breast cancer cells
Ling-Ming Tseng et al.
BREAST CANCER RESEARCH (2012)
Multiple facets of nuclear periphery in gene expression control
Ghislaine Arib et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Low expression of PP2A regulatory subunit B55α is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patients
P. P. Ruvolo et al.
LEUKEMIA (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
B55β-Associated PP2A Complex Controls PDK1-Directed Myc Signaling and Modulates Rapamycin Sensitivity in Colorectal Cancer
Jing Tan et al.
CANCER CELL (2010)
Protein kinase C-related kinase targets nuclear localization signals in a subset of class IIa histone deacetylases
Brooke C. Harrison et al.
FEBS LETTERS (2010)
Ceramide Produces Apoptosis Through Induction of p27kip1 by Protein Phosphatase 2A-dependent Akt Dephosphorylation in PC-3 Prostate Cancer Cells
Sang Woo Kim et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2010)
Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
Aslaug Aa Muggerud et al.
BREAST CANCER RESEARCH (2010)
Loss of Histone Deacetylase 4 Causes Segregation Defects during Mitosis of p53-Deficient Human Tumor Cells
Bruno Cadot et al.
CANCER RESEARCH (2009)
Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling
Archana Mukhopadhyay et al.
FASEB JOURNAL (2009)
PR55α, a Regulatory Subunit of PP2A, Specifically Regulates PP2A-mediated β-Catenin Dephosphorylation
Wen Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
Kuen-Feng Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling
Barbara Illi et al.
CIRCULATION RESEARCH (2008)
PP2A regulates HDAC4 nuclear import
Gabriela Paroni et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis
Maud Martin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Serine-7 of the RNA polymerase IICTD is specifically required for snRNA gene expression
Sylvain Egloff et al.
SCIENCE (2007)
Dephosphorylation and caspase processing generate distinct nuclear pools of histone deacetylase 4
Gabriela Paroni et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Histone deacetylase 4 is required for TGFβ1-induced myofibroblastic differentiation
Wendy Glenisson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Negative regulation of Pim-1 protein kinase levels by the B56β subunit of PP2A
J. Ma et al.
ONCOGENE (2007)
PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation
Alessio Zippo et al.
NATURE CELL BIOLOGY (2007)
Laminopathies: A wide spectrum of human diseases
Howard J. Worman et al.
EXPERIMENTAL CELL RESEARCH (2007)
Stromal myofibroblasts predict disease recurrence for colorectal cancer
Tadashi Tsujino et al.
CLINICAL CANCER RESEARCH (2007)
Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity
Kelly Lynn Harms et al.
CANCER RESEARCH (2007)
Inhibition of alpha interferon signaling by hepatitis B virus
Verena Christen et al.
JOURNAL OF VIROLOGY (2007)
Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A
Carmen C. Sucharov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Phospho-specific binding of 14-3-3 proteins to phosphatidylinositol 4-kinase III β protects from dephosphorylation and stabilizes lipid kinase activity
Angelika Hausser et al.
JOURNAL OF CELL SCIENCE (2006)
PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum
Stephen S. Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Regulation of protein phosphatase 2A-mediated recruitment of IQGAP1 to β1 integrin by EGF through activation of Ca2+/calmodulin-dependent protein kinase II
Kazuhide Takahashi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Protein phosphatase 2A regulatory subunit b56α associates with c-Myc and negatively regulates c-Myc accumulation
HK Arnold et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK
C Letourneux et al.
EMBO JOURNAL (2006)
γ-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair
D Chowdhury et al.
MOLECULAR CELL (2005)
Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1
FHT Duong et al.
JOURNAL OF VIROLOGY (2005)
Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II
D Baillat et al.
CELL (2005)
Increases in intracellular calcium dephosphorylate histone H3 at serine 10 in human hepatoma cells:: Potential role of protein phosphatase 2A-protein kinase CoβII complex
W Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Cancer-associated PP2A Aα subunits induce functional haploinsufficiency and tumorigenicity
W Chen et al.
CANCER RESEARCH (2005)
Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation
HS Choi et al.
CANCER RESEARCH (2005)
Global histone modification patterns predict risk of prostate cancer recurrence
DB Seligson et al.
NATURE (2005)
Drosophila Twins regulates Armadillo levels in response to Wg/Wnt signal
R Bajpai et al.
DEVELOPMENT (2004)
Protein phosphatase 2A positively regulates ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites
S Ory et al.
CURRENT BIOLOGY (2003)
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells
Y Matsuoka et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo
SH Chao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor
HB Wang et al.
SCIENCE (2001)
Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1
BD Strahl et al.
CURRENT BIOLOGY (2001)
PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells
J Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Regulation of histone deacetylase 4 by binding of 14-3-3 proteins
AH Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
